Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Breakthrough daptomycin-, linezolid-, vancomycin-resistant Enterococcus faecium bacteremia during protracted daptomycin therapy: A case report

IDCases(2022)10.1016/j.idcr.2022.e01593Source: DataRank Database

Breakthrough daptomycin-, linezolid-, vancomycin-resistant Enterococcus faecium bacteremia during protracted daptomycin therapy: A case report is a research paper published in IDCases (2022). On theSindex it has a DataRank of 0.208. It has been cited 3 times.

N/A

0.208DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.19)OA: goldTopics (39)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.208

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (6)

Tejas Joshi ORCID,Samuel W.M. Gatesy,Omar Al-Heeti,William J Moore ORCID,Kelly E. R. Bachta ORCID

Live enrichment

PubMed:35966277 PMC:PMC9372734 OpenAlex:https://openalex.org/W4289755584

American Cancer Society

Grant: 134251-CSDG-20-053-01-MPC

National Cancer Institute

Grant: CCSG P30 CA060553

National Institute of General Medical Sciences

Grant: T32 GM008152

Office of Research-Wichita, School of Medicine, University of Kansas

Office of the Provost, University of South Carolina

Feinberg School of Medicine

National Institutes of Health

Northwestern University

FWCI

0.19

Citation Percentile

0.5%

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://www.sciencedirect.com/science/article/pii/S2214250922002219/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S2214250922002219/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2214250922002219?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2214250922002219?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.idcr.2022.e01593

Fields of Study

Antimicrobial Resistance in StaphylococcusBacterial Identification and Susceptibility TestingAntibiotic Resistance in Bacteria

Keywords

DaptomycinLinezolidEnterococcus faeciumMedicineBacteremiaVancomycinMicrobiologyEnterococcusVancomycin-resistant EnterococcusAntibioticsBiologyStaphylococcus aureusBacteriaCase ReportWhole Genome SequencingVancomycin-resistant Enterococcus FaeciumWgs, Whole Genome SequencingMdr, Multidrug ResistantSt, Sequence TypeMic, Minimal Inhibitory ConcentrationPod, Post-operative DayPicc, Peripherally Inserted Central CatheterLinezolid-resistanceLzd, LinezolidLlq, Left Lower QuadrantDnse, Daptomycin-non-susceptible EnterococciPbp5, Penicillin Binding Protein 5Clabsi, Central Line-associated Bloodstream InfectionCpt, CeftarolineDap, DaptomycinDlvre, Daptomycin-, Linezolid-, Vancomycin-resistant Enterococcus FaeciumDaptomycin-resistanceSynergy Antimicrobial Resistance TestingEfm, Enterococcus FaeciumIa, IntraabdominalP1–5, Plasmids 1–5

Sustainable Development Goals

SDG 0: Good health and well-being